NantHealth, Inc. (NH) [Rocket]

Overview

NantHealth, Inc. (NH)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/05/2023	8-K	Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
09/26/2023	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership:
08/15/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/27/2023	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/26/2023	8-K	Other Events  Interactive Data
05/23/2023	8-K	Other Events  Interactive Data
05/22/2023	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Sep-30-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	62.6	73.2	0.3	77.4	89.5	86.7	80.4	46.2
Revenue growth	-14.4%	-5.5%		-13.5%	3.2%	7.8%	74.1%	36.1%
Cost of goods sold	27.8	29.2	0.0	34.1	44.3	41.5	44.1	20.7
Gross profit	34.8	43.9	0.3	43.3	45.2	45.2	36.3	25.5
Gross margin	55.6%	60.1%	100.0%	55.9%	50.5%	52.1%	45.1%	55.2%
Selling, general and administrative	52.1	48.5	0.0	55.6	70.8	75.0	105.3	55.7
Research and development	19.7	17.3		13.9	20.9	33.9	47.3	14.2
EBITA	-32.0	14.6	-7.8	-13.3	66.9	-1.9	-57.0	-29.8
EBITA margin	-51.0%	19.9%	-2236.7%	-17.1%	74.7%	-2.2%	-70.9%	-64.5%
Amortization of intangibles	8.9	8.4		8.9	9.2	15.7	22.5	12.1
EBIT	-40.9	6.2	-7.8	-22.1	57.7	-17.6	-79.5	-41.9
EBIT margin	-65.3%	8.4%	-2236.7%	-28.6%	64.5%	-20.3%	-98.9%	-90.8%
Pre-tax income	-58.5	-88.0	-2.6	-66.4	-194.1	-133.6	-164.3	-45.3
Income taxes	0.1	0.4	-0.1	-1.0	-3.7	-2.2	-23.8	0.4
Tax rate			2.3%	1.5%	1.9%	1.6%	14.5%
Net income	-116.8	-144.8	-2.6	-128.1	-192.2	-175.2	-184.1	-72.0
Net margin	-186.5%	-197.8%	-750.1%	-165.5%	-214.8%	-202.1%	-229.0%	-155.9%

Diluted EPS	($1.02)	($1.30)		($1.16)	($1.74)	($1.13)	($1.21)	($0.46)
Shares outstanding (diluted)	114.1	111.0		110.4	109.2	116.7	116.6	99.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.